Radwan Alkhatib

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Cross Sectional

Medical Students

Metastatic Colorectal Cancer

Top Venues

JCO global oncology

Advances in medical education and practice

This page only lists publications with an associated author ORCID identifier.

Publications

Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, Yasmin Tuleimat, Nashwa Abdel-Aziz, Mervat Mahrous, Shereef Elsamany, Tusneem Elhassan, Mohammed Alghamdi
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study. JCO global oncology 10 (2024)
Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, Yasmin Tuleimat, Nashwa Abdel-Aziz, Mervat Mahrous, Shereef Elsamany, Tusneem Elhassan, Mohammed Alghamdi
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study. JCO global oncology 10 (2024)
Mohammed Al Mairi, Yasmin Youssef, Ahmad Alhamshari, Radwan Alkhatib, Hamzah Koujan, Anas Alkhabaz, Aniko Szabo
Assessing the Learning Environment Perception Among Medical Students at a Tertiary Referral Hospital in Saudi Arabia. Advances in medical education and practice 15 (2024)
Mohammed Al Mairi, Yasmin Youssef, Ahmad Alhamshari, Radwan Alkhatib, Hamzah Koujan, Anas Alkhabaz, Aniko Szabo
Assessing the Learning Environment Perception Among Medical Students at a Tertiary Referral Hospital in Saudi Arabia. Advances in medical education and practice 15 (2024)
Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, Yasmin Tuleimat, Nashwa Abdel-Aziz, Mervat Mahrous, Shereef Elsamany, Tusneem Elhassan, Mohammed Alghamdi
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study. JCO global oncology 10 (2024)
Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, Yasmin Tuleimat, Nashwa Abdel-Aziz, Mervat Mahrous, Shereef Elsamany, Tusneem Elhassan, Mohammed Alghamdi
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study. JCO global oncology 10 (2024)